These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11226270)

  • 21. COX-2 correlates with F-box protein, Skp2 expression and prognosis in human gastric carcinoma.
    Honjo S; Kase S; Osaki M; Ardyanto TD; Kaibara N; Ito H
    Int J Oncol; 2005 Feb; 26(2):353-60. PubMed ID: 15645119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. STAT1 represses Skp2 gene transcription to promote p27Kip1 stabilization in Ras-transformed cells.
    Wang S; Raven JF; Koromilas AE
    Mol Cancer Res; 2010 May; 8(5):798-805. PubMed ID: 20407011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. S-phase kinase-associated protein 2 knockdown blocks colorectal cancer growth via regulation of both p27 and p16 expression.
    Xu SY; Wang F; Wei G; Wang B; Yang JY; Huang YZ; Zhang L; Zheng F; Guo LY; Wang JN; Tang JM
    Cancer Gene Ther; 2013 Dec; 20(12):690-4. PubMed ID: 24336114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The F-box protein SKP2 binds to the phosphorylated threonine 380 in cyclin E and regulates ubiquitin-dependent degradation of cyclin E.
    Yeh KH; Kondo T; Zheng J; Tsvetkov LM; Blair J; Zhang H
    Biochem Biophys Res Commun; 2001 Mar; 281(4):884-90. PubMed ID: 11237742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retinoic acid decreases targeting of p27 for degradation via an N-myc-dependent decrease in p27 phosphorylation and an N-myc-independent decrease in Skp2.
    Nakamura M; Matsuo T; Stauffer J; Neckers L; Thiele CJ
    Cell Death Differ; 2003 Feb; 10(2):230-9. PubMed ID: 12700651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bortezomib (Velcade) induces p27Kip1 expression through S-phase kinase protein 2 degradation in colorectal cancer.
    Uddin S; Ahmed M; Bavi P; El-Sayed R; Al-Sanea N; AbdulJabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Hussain AR; Al-Kuraya KS
    Cancer Res; 2008 May; 68(9):3379-88. PubMed ID: 18451165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of p27(KIP1) degradation by Skp2 in the regulation of proliferation in response to wounding of corneal epithelium.
    Yoshida K; Nakayama K; Nagahama H; Harada T; Harada C; Imaki J; Matsuda A; Yamamoto K; Ito M; Ohno S; Nakayama K
    Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):364-70. PubMed ID: 11818378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell cycle-dependent regulation of the Skp2 promoter by GA-binding protein.
    Imaki H; Nakayama K; Delehouzee S; Handa H; Kitagawa M; Kamura T; Nakayama KI
    Cancer Res; 2003 Aug; 63(15):4607-13. PubMed ID: 12907639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. c-myc and skp2 coordinate p27 degradation, vascular smooth muscle proliferation, and neointima formation induced by the parathyroid hormone-related protein.
    Sicari BM; Troxell R; Salim F; Tanwir M; Takane KK; Fiaschi-Taesch N
    Endocrinology; 2012 Feb; 153(2):861-72. PubMed ID: 22210745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of p27(Kip1) cooperates with cyclin E in T-cell lymphomagenesis.
    Geisen C; Karsunky H; Yücel R; Möröy T
    Oncogene; 2003 Mar; 22(11):1724-9. PubMed ID: 12642875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p27Kip1 repression of ErbB2-induced mammary tumor growth in transgenic mice involves Skp2 and Wnt/beta-catenin signaling.
    Hulit J; Lee RJ; Li Z; Wang C; Katiyar S; Yang J; Quong AA; Wu K; Albanese C; Russell R; Di Vizio D; Koff A; Thummala S; Zhang H; Harrell J; Sun H; Muller WJ; Inghirami G; Lisanti MP; Pestell RG
    Cancer Res; 2006 Sep; 66(17):8529-41. PubMed ID: 16951165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inverse relationship between Skp2 ubiquitin ligase and the cyclin dependent kinase inhibitor p27Kip1 in prostate cancer.
    Ben-Izhak O; Lahav-Baratz S; Meretyk S; Ben-Eliezer S; Sabo E; Dirnfeld M; Cohen S; Ciechanover A
    J Urol; 2003 Jul; 170(1):241-5. PubMed ID: 12796697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic impact of Skp2 and p27 in human breast cancer.
    Traub F; Mengel M; Lück HJ; Kreipe HH; von Wasielewski R
    Breast Cancer Res Treat; 2006 Sep; 99(2):185-91. PubMed ID: 16636894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hormonal induction of adipogenesis induces Skp2 expression through PI3K and MAPK pathways.
    Auld CA; Caccia CD; Morrison RF
    J Cell Biochem; 2007 Jan; 100(1):204-16. PubMed ID: 16924675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of Skp2 and its substrate CDKN1B (p27) in colorectal cancer.
    Bochis OV; Irimie A; Pichler M; Berindan-Neagoe I
    J Gastrointestin Liver Dis; 2015 Jun; 24(2):225-34. PubMed ID: 26114183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of p27 and its ubiquitin ligase subunit Skp2 in upper urinary tract transitional cell carcinoma.
    Langner C; von Wasielewski R; Ratschek M; Rehak P; Zigeuner R
    Urology; 2004 Sep; 64(3):611-6. PubMed ID: 15351619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of the S-phase kinase-associated protein 2 in thyroid cancer.
    Chiappetta G; De Marco C; Quintiero A; Califano D; Gherardi S; Malanga D; Scrima M; Montero-Conde C; Cito L; Monaco M; Motti ML; Pasquinelli R; Agosti V; Robledo M; Fusco A; Viglietto G
    Endocr Relat Cancer; 2007 Jun; 14(2):405-20. PubMed ID: 17639054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pim1 cooperates with E2a-Pbx1 to facilitate the progression of thymic lymphomas in transgenic mice.
    Feldman BJ; Reid TR; Cleary ML
    Oncogene; 1997 Nov; 15(22):2735-42. PubMed ID: 9401000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EGCG stabilizes p27kip1 in E2-stimulated MCF-7 cells through down-regulation of the Skp2 protein.
    Huang HC; Way TD; Lin CL; Lin JK
    Endocrinology; 2008 Dec; 149(12):5972-83. PubMed ID: 18719023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Skp2-SCF E3 ligase regulates Akt ubiquitination, glycolysis, herceptin sensitivity, and tumorigenesis.
    Chan CH; Li CF; Yang WL; Gao Y; Lee SW; Feng Z; Huang HY; Tsai KK; Flores LG; Shao Y; Hazle JD; Yu D; Wei W; Sarbassov D; Hung MC; Nakayama KI; Lin HK
    Cell; 2012 May; 149(5):1098-111. PubMed ID: 22632973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.